The human ®brosarcoma cell line, HT1080, clone H4, was used to determine if the transformation suppressive functions of p53 and Egr-1 have the same underlying mechanism. This cell line expresses only mutant p53 and no detectable Egr-1. H4 clones stably expressing Egr-1 are less transformed in proportion to the level of Egr-1 expressed, acting through the induction of the TGFb1 gene. Here, H4 cells and the highest Egr-1 expressing clone were transfected with a vector expressing normal human p53 to derive stable clones expressing p53. The expression of p53 in H4 cells inhibited transformed growth and reduced tumorigenicity. The eect of coexpression of both p53 and Egr-1 was additive, producing cell lines with 30% of normal growth rate and sevenfold reduced tumorigenicity compared with control lines. These results indicated that each factor may act independently by dierent pathways, although each additively increased the level of p21 WAF1 cell cycle inhibitor. However, exposure of the H4-derived cells to UV-C irradiation produced contrasting eects. Cell cycle analyses showed that the presence of p53 was associated with loss of the G1 and S cells to apoptosis after irradiation. In contrast, the expression of Egr-1 increased entry into S/G2 phase of the cell cycle with little apoptosis via a mechanism involving elevated FAK and low caspase activities. Apoptosis was observed only in the cell lines that expressed no Egr-1, especially those expressing wt-p53, and was preceded by high caspase activity. In summary, Egr-1 suppressed transformation and counteracted apoptosis by the coordinated activation of TGFb1, FN, p21 and FAK, leading to enhanced cell attachment and reduced caspase activity. In the doubly expressing cell line, the survival eect of Egr-1 was dominant over the apoptotic eect of p53.
Introduction
HT1080 are highly tumorigenic cells derived from a human ®brosarcoma. A subclone, H4, (Frisch, 1994) was used to derive cells that constitutively expressed wild-type (wt) tumor suppressor p53 as well as endogenous but mutant (inactive) p53. In addition, we derived clones that also over-expressed the Egr-1 gene, either singly or together with p53. H4 cells that constitutively express the Egr-1 gene have been shown to suppress anchorage dependent and independent growth and tumorigenicity . Tumor suppressive properties are also ascribed to p53 (Merlo et al., 1994) , although this has not been tested in HT1080 cells until now.
The mechanism for the abrogation of transformed growth and tumorigenicity in H4 cells by Egr-1 has been shown to be predominantly by the increased production of TGFb1, which is growth inhibitory for Egr-1 transfected H4 cell clones . The TGFb1 promoter has Egr-1 binding sites and a reporter construct was used to demonstrate that Egr-1 stimulates the transcriptional activity of the promoter. The increased active TGFb was shown to be produced in amounts that largely explained the growth suppressive properties of Egr-1 in H4 cells. TGFb is known to act by inducing the activity of the p21 gene, thus producing higher levels of this cell cycle inhibitor and increasing the duration of the G1 phase of the cell cycle (Akagi et al., 1996) . Therefore, Egr-1 can have a protective eect on H4 and other cells, leading to their increased survival after DNA damage or other stresses (Huang et al., 1996; .
Stresses such as UV strongly induce Egr-1, together with p53 and about 100 other genes (Keyse, 1993; Weichselbaum et al., 1994) . Some of the gene responses lead to cell death by apoptosis, and some lead to DNA repair and recovery of the cell cycle. p53 is able to direct the cell into either of these pathways Liebermann et al., 1995; Sabbatini et al., 1995; Smith et al., 1995) . We have shown that increased Egr-1 production is part of the stress response that contributes to signals leading to survival . The mechanism of this response involves reactive oxygen species (ROS) and signals are generated chie¯y by the epidermal growth factor receptor (Huang et al., 1996) . The p53 gene is also induced by UV irradiation, but whereas the Egr-1-inducing signal is largely generated by ROS from the cell membrane, for p53, DNA damage is thought to be the major stimulus .
The activities of p53 are various and complex . The induction of p53 can lead to cell cycle pausing at either the G1 or G2 stages of the cell cycle (Perry and Levine, 1993) . Its principal mode of action is to increase the levels of cell cycle inhibitors such as p21 that inactivate cell cycle kinases (Del Sal et al., 1996; El-Deiry et al., 1993 . When signals causing genotoxic damage impinge upon cells, p53 is activated and this leads to G1 (and some G2) block of the cell cycle, or to cell apoptosis (programmed cell death). p53 therefore protects the normal cell against proceeding into the S phase when its DNA is damaged. While the tumor suppressive and protective eects are common to both Egr-1 and p53, our analysis suggests that the two proteins act by dierent mechanisms. HT1080 cells express only mutant p53 and no Egr-1, and neither is induced by UV irradiation. We show here that irradiation of HT1080 cells expressing mutant or wt p53 induces apoptosis, while Egr-1 is anti-apoptotic to the cycling cell and overrides death signals from p53. The mechanism of the survival activity of Egr-1 expression in these cells, is due in part to the increased activity of several proteins associated with increased cell¯attening and reduced susceptibility to anoikis, or loss of anchorage and subsequent programmed cell death, as well as to a decrease in active levels of the apoptotic protease, caspase-3.
Results

Constitutive expression of ectopic p53 in H4-derived clones
H4 cells do not express wild-type (wt) p53, but a mutant form was detected by immunoblotting. The antibody used in Figure 1 (top panel) recognized both mutant and wt p53, while only wt p53 was recognized by the antibody used to immunoprecitate p53 ( Figure  1 , middle panel). Cotransfection of pCMVp53 and pPGKhygro into the H4 cell line, followed by selection with hygromycin, lead to the isolation of several clones ( Figure 1 , lanes 3 ± 6) that over-expressed p53. Similarly, cotransfection of the E9 cell line (an H4-derived clone that was previously shown to express Egr-1 constitutively) with pCMVp53 and selection with hygromycin gave rise to several clones that overexpressed p53 as well as Egr-1 (Figure 1 , lanes 7 ± 10). The expression of Egr-1 was determined by immunoblotting and is shown in Figure 1 (bottom panel). The four cell types that resulted were termed H4N (Neoresistant control), H4p53 (expresses wt p53), E9 (expresses wt Egr-1), and E9p53 (expresses both p53 and Egr-1).
Both of the transcription factors, p53 and Egr-1, have been demonstrated to have growth and tumor suppressor characteristics. The question as to whether Egr-1 and p53 could independently or synergistically exert growth suppressive activities in H4 cells was tested in a series of assays.
Growth and transformation suppression by p53 and Egr-1
Growth of the four types of cells in monolayer cultures tested by the MTT proliferation assay is shown in Figure 2a (see Materials and methods). H4N and H4 parental cells grew at the fastest rate and achieved higher cell densities as demonstrated earlier . The slowest growing lines were the cells expressing both Egr-1 and p53, while the single transfectants were intermediate in rate. These results were supported by assays that measured the rate of incorporation of tritiated thymidine by the cell lines. Figure 2b indicates the same relative growth rates for each cell line as shown in the MTT assay.
The ability of cells to grow on a substrate at low density (clonogenic or colony-forming assay) was examined and this showed that clonogenicity was less in cells that expressed either p53 or Egr-1 and was very low in H4 cells that expressed both factors (Figure 3a,  b) . These assays consistently demonstrated an additive eect of Egr-1 and p53 on the suppression of growth and clonogenicity.
Since the cell cycle inhibitor, p21/WAF1/CIP, might account for slow growth in the cell lines that express wt-p53 or Egr-1 expression via TGFb induction (Landesman et al., 1997; Liu et al., 1996; Wu and Levine, 1997) , we tested for p21 WAF1 levels in each cell line. Immunoblot studies indicated that the levels of p21 were elevated in H4p53 (14-fold) and E9 (fourfold) cells, compared to H4 parental cells which expressed a very level of p21. This level was taken as 1.0 after being normalized by reference to the level of actin detected (Figure 3c ). On this basis, the expression of doubly-expressing cells, induction was 18-fold ( Figure 3c ). This eect on p21 induction by exogenously expressed p53 indicates that this gene is transcriptionally active in these cells. Similarly, we have shown that Egr-1 is transcriptionally active in E9 cells as indicated by the induction of the TGFb1 gene (Liu et al., 1998) . UV-C irradiation however, led to reduction in p21 levels in all cells, with detectable levels remaining only in Egr-1 expressing cells. Since p53 and Egr-1 are expressed from exogenous CMV promoters, they are not expected to be radiation inducible as in normal cells and therefore would not lead to increases in p21 gene activation. The reduced p21 levels seen after UV irradiation con®rms recent observations that p21 is a substrate for caspases activated during apoptosis (Gervais et al., 1998; Park et al., 1998) . One in vitro measure of transformed growth is the ability of cells to exhibit anchorage independent growth. Soft agar growth assays clearly demonstrated that H4N and H4 cells grew numerous colonies ( Figure  4 ) by the end of the 14-day period and these were large enough to be visible upon inspection, even when unstained. The colonies of cells expressing either p53 or Egr-1 were fewer and smaller, while the doublyexpressing cells were unable to grow anchorage independently (Figure 4 , two right panels). These 
Tumorigenicity tests
H4 cells are highly tumorigenic after subcutaneous injection into athymic nu/nu mice. Several clones of each of the four cell types were tested for tumor`take' and rate of tumor growth. The rates of tumor growth of the various cell lines were statistically dierent from each other as compared in the groupings shown in Table 1 . Only H4p53 and H4E9 were not statistically dierent from each other. The probability of dierence between the doubly transfected lines and the parental controls was statistically signi®cant (P=0.0001) as was the dierence between single transfectant lines and parental controls (P=0.05 and 0.003). Thus, the tumorigenicity studies con®rmed that both gene products conferred suppressive properties, and these were additive when expressed together. It is likely that the two tumor suppressors act by dierent mechanisms and this was tested next.
Egr-1 does not stimulate p53 expression in H4 cells
It has been reported that Egr-1 binds to and induces 5' promoter/enhancer elements of the p53 gene and achieves tumor suppressive eects indirectly (Nair et al., 1997) . Egr-1 is also a major cell component detected by SAGE analysis of rat embryo ®broblasts expressing wt p53 (Madden et al., 1997) . We tested for the possibility that induction of p53 by Egr-1 might explain the tumor suppressor properties of Egr-1 by determining the levels of p53 mRNA by Northern blotting. The levels of p53 mRNA were not higher in Egr-1-expressing cells (H4E9) and in fact were somewhat lower (data not shown). Both Egr-1 and p53 are normally inducible by UV and ionizing irradiation, but in H4 cells, we have documented that Egr-1 is not inducible (Huang et al., 1998a) . After UV irradiation, the levels of p53 mRNA were somewhat reduced over a 24 h time course, demonstrating that neither Egr-1 nor irradiation induces the p53 gene in H4 cells and this conclusion is further supported by the invariant levels of p53 protein shown in Figure 1 .
Cell cycle analyses show that constitutive p53 and Egr-1 aect cell responses to UV In our ®ve dierent clones, either there is no wt p53 expression (H4, H4N and H4E9), or there is exogenous p53 expression (H4p53) or both Egr-1 and p53 are expressed (E9p53). Since the exogenous genes are driven by the CMV promoter, they are not transcriptionally induced by UV although at least Egr-1 protein becomes phosphorylated (Huang et al., 1998a) . The proportion of cells at each stage of the cell cycle was determined by¯ow cytometry in order to determine the eect of UV on the cell cycle ( Figure 5 ). The two main conclusions were that UV induced a prominent apoptotic peak (35%) in cells that expressed p53 but not in cells that expressed Egr-1. The apoptotic population was largely derived from the G1+S stage cells, which fell 27% after UV. Secondly, the simultaneous expression of Egr-1 prevented apoptosis induced by p53. Following UV irradiation, cells that expressed Egr-1 had an increased proportion of cells that were in the S phase, rising from 20 ± 30% 24 h after irradiation, suggesting that the cell cycle had resumed and that Egr-1 expression is associated with increased survival.
Apoptosis in p53 expressing cells
In order to verify that apoptosis accounted for the sub-G1 peak in the cell cycle analysis, DNA fragmentation assays were performed. A moderate level of low MW DNA was present in irradiated H4 and H4N cells 12 and 24 h after UV irradiation. When p53 was also present the degree of DNA fragmentation was increased, therefore both p53 dependent and independent responses were ocurring, following irradiation. In contrast, in E9 cells, little DNA laddering was seen Figure 4 Anchorage-independent growth of HT1080-derived cell lines. Both the number of colonies and the size of the colonies were reduced by the expression of Egr-1 and/or p53 (Figure 6a ) indicating dierent responses to the two gene products with Egr-1 acting to protect the cells against apoptosis induced by p53. The survival activity of Egr-1 was clearly indicated by the abrogation of the apoptotic eects of p53 in E9p53 cells, since only a low level of DNA laddering was seen at 24 h in these cells (Figure 6a ). These tests indicated that the survival eects of Egr-1 negate the apoptotic activities of p53, further underscoring their dierent responsive pathways. These results support the observations based on cell cycle analyses.
The signaling pathways are intact in HT1080-derived cell lines
Lack of induction of Egr-1 in H4 cells could be interpreted as a result of altered signaling pathways, but that is unlikely because there was a detectable level of active Erk-1 MAPK in all the cell lines. When growth factors or other stimuli lead to mitogenesis in cells, Egr-1 is rapidly induced in a pathway via Ras and MAP kinase activation (Huang et al., 1994b (Huang et al., , 1996 . There was little variation in Erk-1 MAPK activity in three of the cell lines, with a small increase in H4 cells that expressed wt p53, 2 h after UV-C irradiation (Figure 6b ). On the other hand, Jun kinase (JNK) was strongly activated in all cell lines after irradiation. Figure 6c shows that the activation of JNK upon UV irradiation occurred in all cell lines with the same kinetics, indicating that this stress activated kinase pathway responded normally. While our results do not indicate a defective JNK pathway in any of the cell lines, we did observe higher basal JNK activity in Egr-1 and p53 transfected cells. Thus, the possibility remains that Egr-1 and p53 expression have an eect on stress activated kinase levels, but this by itself cannot account for the dierences in sensitivity to UV irradiation. The status of the inherent caspase activities often underlies basal dierences in cells that have dierent sensitivities to apoptotic stimuli, and p53 protein is known to induce the activation of CPP32b (caspase 3) (Fuchs et al., 1997) . We measured the activity of caspase 3 as the major`executioner' protease of the apoptotic cascade using a sensitive¯uorescent substrate cleavage assay in the four cell types (see Materials and methods). The caspase 3 activity measured 4 and 8 h after UV-C irradiation, was found to be signi®cantly higher in H4p53 and H4 cells, while the lowest level was in E9p53 (Figure 7) . We found similar dierences in the levels of Caspase 8 (one of the initiator caspases) among the four cell lines (data not shown), again illustrating the dominance of Egr-1's anti-apoptotic eect, and the dominance of Egr-1 over p53.
p53 induces the expression of a number of proteins, and we tested for dierential expression of gene products that would account for increased sensitivity to apoptotic signals, but found no signi®cant differences in Bax levels in the dierent cell lines (data not Figure 5 Fluorescence-activated cell cytometry of subcon¯uent cells derived from the HT1080 line, before irradiation (a) and 16 h after 40 J/m 2 UV-C (b). The main peak on the left of each panel represents cells in G1 and G0. DNA appearing to the left of this peak is present in sub diploid cell fragments, and is taken to be due to apoptosis. One of three similar assays is shown 
-1 expressing cells, as described earlier (Huang et al., 1998b) , a feature that would decrease survival rather than increase it. Fas/APO1, the cell death-associated ligand was not expressed in these cells, while the apoptosis inhibitor XIAP/hIAP was expressed strongly at similar levels in all the cell lines (data not shown). The Mdm2 gene is known to be induced by p53 especially after irradiation of cells (Chang et al., 1998) , but this p53 regulatory protein was not increased in expression after UV treatment in our cells, and instead, selectively declined in all cell types after UV (data not shown). We found no dierences among the four cell types in the levels of other cell cycle related gene products, proliferating cell nuclear antigen (PCNA), cyclin D1 and retinoblastoma protein (Rb), measured by immunoblotting before and after UV irradiation (data not shown).
Egr-1 suppresses anoikis in HT1080 cells
HT1080 are ®brosarcoma cells with the ability to convert to an epithelioid phenotype (Frisch and Francis, 1994) . Disruption of the epithelial cell-matrix interactions is said to induce apoptosis, a phenomenon termed anoikis (Frisch, 1994) . Interactions of integrins with the extracellular matrix proteins can activate focal adhesion kinase (FAK) and suppress apoptosis in normal epithelial cells (Frisch et al., 1996) and HT1080 cells transfected with Egr-1 become more epithelioid in character and have a¯atter spread appearance . We therefore analysed the four cell types for their expression of FAK and the related kinase PYK-2 activities under conditions where the densities of cells were matched for each sample. Figure 8 demonstrates that there are inherent dierences in FAK protein levels expressed in the four cell lines, with the highest expression in cells that express both Egr-1 and p53. More importantly, the levels of FAK activity were dierent in the four cell lines, measured as levels of tyrosine phosphorylated FAK. There was 11-fold higher FAK activity in E9p53 cells than in H4p53 cells and 2 ± 3-fold higher in E9 cells than in H4 cells both before and after irradiation. As a further measure of FAK activity, the focal adhesion substrate for FAK, paxillin, was examined. Consistent with the low FAK activity in p53 transfected cells, the level of paxillin phosphorylation was also low, while it was highest in the E9p53 cells that survived stress best. There was no detectable PYK-2 in any of the cell lines (data not shown). In summary, cells that express Egr-1 have increased FAK activity and this acts to protect the cells from apoptosis (Xu et al., 1996) . Since the same high level of FAK activity was retained after UV irradiation, the same eect also occurs in irradiated cells and explains, at least in part, the resistance to apoptosis endowed by Egr-1 expression in these cells. In support of this hypothesis, clones E9 and E4, which Figure 8 Immunoprecipitation and immunoblotting of lysates of HT1080-derived cells. Immunoprecipitation was done using the ®rst antibody (IP) and the immune complexes were analysed by SDS ± PAGE, and blots were incubated with the indicated antibody (Blot). The activity of FAK (line 2) is indicated by the signal using an antibody to tyrosine phosphate (P-Tyr). The foldincrease is an average of two experiments. The levels of paxillin expressed and the levels of paxillin tyrosine phosphorylation, a substrate of FAK, are shown in the bottom two panels Figure 9 Proposed mechanisms for growth suppression and survival in HT1080 cells express the highest levels of Egr-1, express up to 38-fold higher levels of ®bronectin, by the transactivation of the FN gene by Egr-1, and furthermore, the plasminogen activator inhibitor (PAI-1) gene is upregulated ®vefold in Egr-1-expressing cells (Liu et al., 1998) . Both of these gene products have antiapoptotic or survival eects by increasing cell spreading and integrin-ligand interactions (Planus et al., 1997; Scott et al., 1997; Xu et al., 1996; Zhang et al., 1995) .
Discussion
Egr-1 is a tumor suppressor-like gene with many properties in common with p53. We have shown that Egr-1 has transformation suppressive properties in HT1080-derived cells and in mammary cells (Huang et al., , 1997 . Egr-1 expression is absent and is not inducible in H4 cells treated with stimuli such as serum, phorbol esters and UV irradiation (Huang et al., 1998a) . Egr-1 expression has also been lost from a number of mammary cell lines and is low in human mammary tumor samples compared to normal tissue (Huang et al., 1997) . Restoration of Egr-1 expression suppresses all the transformed characteristics of mammary, glial and the ®brosarcoma cell line studied here (Huang et al., , 1997 . p53 is a well established tumor suppressor gene and it is known to be mutated in a majority of tumors and tumor cell lines including H4 cells. The introduction of exogenous wt p53 into cells expressing mutant p53 has been shown to inhibit growth in numerous cases Del Sal et al., 1996; Diller et al., 1990; Merlo et al., 1994) reviewed by Levine . Mutations of Egr-1 have not been well studied yet, but a report shows that Egr-1 is mutated in some prostate cancer cell lines , therefore, the criteria that characterize Egr-1 as a tumor suppressor gene are accumulating.
The lack of response of H4 cells to all kinds of stimuli could be explained by losses in downstream intermediaries of the UV signal transduction pathway, thus blocking signals from reaching the nucleus after stimulation. However, in these cells, two major signaling pathways, JNK and Erk-1 MAPK, are active. The fact that vector-expressed proteins elicited strong responses (growth retardation, increases in p21 expression, and increases in FAK) indicates that functional molecules were produced. Re-expression of Egr-1 in H4 cells bestowed cell cycle inhibition additively with p53 re-expression, through the induction of p21 WAF1 . In marked contrast to p53, Egr-1 expression prevented apoptosis after UV irradiation, as seen in three dierent assays. While cells with active p53 had pronounced losses of G1 cells as apoptotic products, Egr-1-expressing cells showed increased entry of cells into the S phase. Egr-1 expression also protected cells from cell death after ionizing radiation in several dierent cell types by a similar mechanism (Hallahan et al., 1995) . H4 cells that lacked Egr-1 were lost from the G1+S phases of the cell cycle as an apoptotic fraction of fragmented DNA ( Figure 5 ). While p53 mainly promoted its apoptotic pathway after irradiation, Egr-1 was able to overcome this eect by blocking apoptosis.
Thus, Egr-1 and p53 appear to be tumor suppressors that act independently, with Egr-1 dominating over p53 in its cell survival role after irradiation.
The mechanism for the survival activities of Egr-1 Egr-1 can also induce apoptosis under certain conditions. The expression of Egr-1 in some cell types is known to be required for apoptosis following stress stimuli (Ahmed et al., 1996 Muthukkumar et al., 1995; Nair et al., 1997) . In other cases, Egr-1 has been shown to counteract apoptosis (Hallahan et al., 1995; Kieser et al., 1996; Muthukkumar et al., 1997) , possibly by stimulating the dierentiation of the cells (Nguyen et al., 1993; Sukhatme et al., 1988) . We show here the best example so far, of the anti-apoptotic eects of Egr-1. The UV irradiation of HT1080 cells produces a strong apoptotic signal only if wild-type p53 is expressed, but even this can be overcome if Egr-1 is also expressed (Figures 5 and 6) . We have been unable to ®nd any evidence for the interaction of Egr-1 with p53 that might inactivate it.
A recent report suggests that Egr-1 can induce the transcriptional activity of the p53 gene leading to increased apoptosis in tumor cells (Nair et al., 1997) , thus explaining why some cell types undergo Egr-1-dependent apoptosis. However, in the H4 cell line, where p53 is mutant, there is no induction of p53 by Egr-1 (Figure 1 ), but UV-C still induces apoptosis in the absence of wt p53 (Figures 5 and 6 ). High levels of apoptosis are associated with high levels of wt p53 in most cell types, and we obtained the expected increases in apoptosis after UV irradiation, in H4p53 cells that re-expressed wt p53.
The mechanism of increased apoptosis in HT1080 clones might be via increased levels of apoptosisassociated proteins such as Bax and Fas/APO1, and/or to decreased levels of anti-apoptotic proteins such as Bcl-2 (Park et al., 1996) and XIAP (Deveraux et al., 1997) . None of these proteins was altered in relation to the observed eects of UV-C on the clones, in spite of the known induction of the Bax gene by p53 (Selvakumaran et al., 1994) , the down-regulation of the Fas gene by Egr-1 in B cells (Dinkel et al., 1997) and the repression of Bcl-2 by Egr-1 (Huang et al., 1998b) . Genes that accompany the entry into S phase of the cell cycle in Egr-1 expressing H4 cells, such as PCNA and Rb were not altered in a consistent way to explain cell survival. Finally, the presence of high levels of Caspase-3 and -8 in non-Egr-1 expressing cells and the low levels in the Egr-1-expressing cells was consistent with apoptosis and survival after irradiation, respectively (Figure 7) . The mechanism of regulation of the Caspase-3 gene is not yet known, but Egr-1 might act to inhibit its transcription or alternatively, might activate an inhibitor of caspases, and this is under investigation.
There are three clues to an additional mechanism for Egr-1-dependent survival after irradiation. First, the E9p53 cells were altered in morphology, being¯atter and more spread than H4. Another clue was the demonstration by Frisch and coworkers, that HT1080 cells could be modulated in their response to loss of adhesion to the matrix, which normally leads to apoptosis (anoikis in this case). When these cells were rendered more epithelial or increased integrin signaling was achieved, they were protected from programmed cell death or anoikis (Frisch, 1996) . The activity of FAK was increased in those cases of protection against anoikis (Frisch et al., 1996) , while the attenuation of FAK expression was shown to induce apoptosis in tumor cell lines (Xu et al., 1996) and in ®broblasts (Hungerford et al., 1996) . A third clue came from a study in which the over-expression of ®bronectin in HT1080 cells reversed the transformed growth characteristics of this cell line (Akamatsu et al., 1996) .
Survival by a combination mechanism
Survival after UV irradiation occurred for two lines of H4 derived cells described here. Only the Egr-1-expressing E9 and E9p53 cells were resistant to apoptosis stimulated by irradiation. Only these two cell types had elevated levels of FAK activity (Figure 8, Xiong and Parsons, 1997) , both before and after irradiation, while the two cell lines with low FAK activity had increased apoptosis levels after UV irradiation, likely because FAK is a substrate for degradation by caspases (Wen et al., 1997) . Moreover, E9 but not H4 cells have been shown to synthesize high levels of ®bronectin (FN) and plasminogen activator inhibitor-1 (PAI-1). Egr-1 acts as a direct transactivator of the FN gene while its stimulation of PAI-1 is through the mediation of TGFb1 (Liu et al., 1998) . It is known that ®bronectin (FN) increases the survival of cells (Globus et al., 1998) , and that PAI-1 serves to stabilize FN and the interactions of the cell with matrix through its inhibition of metalloproteases (Planus et al., 1997) . We conclude that E9 and E9p53 cells survive UV, by a combination of Egr-1-dependent eects, including high levels of FAK, FN and PAI-1 expression that lead to anti-apoptotic behavior. Figure  9 summarizes the eects of the two tumor suppressor gene products on growth and survival in HT1080 cells.
Materials and methods
Cell culture and transfection HT1080 cells, clone H4 (Frisch, 1994) , are human ®brosarcoma tumor cells. These and all lines derived from them, were cultured in DMEM with 10% FBS, penicillin and streptomycin, at 378C and 5% CO 2 . A line over-expressing Egr-1, H4E9 (or simply named E9 in this paper), was produced and characterized as described earlier , together with a control line, H4N, that is neomycinresistant. H4 and E9 cells were transfected with pC53-SN3, a vector that expresses wild-type p53 in mammalian cells, together with DspHygroBg12, to confer hygromycin resistance, using the calcium phosphate precipitation procedure. The p53 vector was kindly provided by Dr B Vogelstein, Johns Hopkins University. The hygromycin resistance vector was obtained from Dr J Trill, Smith Kline and French Laboratories. Cultures were selected with 30 mg/ml hygromycin B (Calbiochem, La Jolla, CA, USA) and clones were isolated by colony selection.
Immunoblotting and immunoprecipitation
Procedures were as previously described (Huang et al., 1994b) . A monoclonal antibody that detects wild-type p53 was used for immunoprecipitation assays (Ab-5, Oncogene Science, Cambridge MA, USA). In immunoblot assays, an anti-peptide antibody, Pab240 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) recognizes both wild-type and mutant p53. In immunoblots, equal amounts of protein in samples were analysed in 7.5% SDS ± PAGE and transferred electrophoretically to polyvinyldi¯uoride membranes (Immobilon, Millipore Corporation, Bedford, MA, USA). The antigens were detected with the speci®c antibodies to Egr-1 or to p53 coupled with the enhanced chemiluminescence kit (ECL, Amersham Corporation, Amersham, UK). The detection of FAK and paxillin was done similarly with one portion of the extract used to detect FAK and paxillin protein by immunoblotting and the other portion to detect the activity of kinase using anti-YP antibodies (Transduction Laboratories, Lexington, KY, USA) to detect phosphorylated proteins. Cell lysates containing 25 mg protein were analysed by immunoblotting to determine the levels of p21 (SC-397, Santa Cruz Biotechnology); mdm2 (antibody OP46, Oncogene Research products); Rb (antibody sc-50, Santa Cruz); PCNA, proliferating cell nuclear antigen, (MO879, DAKO Corporation, Carpinteria, CA, USA); FAS/APO1, an intermediate on the apoptotic pathway (antibody F22120, Transduction Laboratories, a generous gift from Dr Xiaokun Zhang) and XIAP, an inhibitor of apoptosis, (antibody hILP, from Transduction Laboratories, a kind gift from Dr J Reed of this Institute).
For p53 immunoprecipitation, cells were metabolically labeled with 35 S-methionine and cysteine (ICN, Irvine, CA, USA) and radioactive cell lysates were incubated with Ab-5 (anti-p53). Antibody-antigen complexes were collected on Protein A Sepharose, washed and analysed by SDS ± PAGE and autoradiography (overnight exposures of ®lm).
Cell growth assays
Growth assays were performed essentially as described (Huang et al., 1994a .
MTT assay (Promega, Madison, WI, USA) Cells were seeded at 1000 per well in 96-well plates and allowed to proliferate for several days as indicated. The cells were stained according to the manufacturer's instructions and the relative numbers of cells were estimated by the absorbance at 600 nm. Each assay was done in triplicate wells and repeated at least twice.
Tritiated thymidine incorporation Cells were seeded at 10 000 cells per well in 24-well plates and allowed to grow for 2 days before adding 1.0 mCi/well tritiated thymidine for 2 h. The cells were washed in PBS, ®xed in methanol-acetic acid (3 : 1) for 15 min, dissolved in 0.3 N NaOH and counted in a scintillation counter.
Clonogenicity assay Cells were seeded at 500 cells/60 mm plate followed by refeeding every 3 days. After 3 weeks, the colonies were ®xed in 4% formaldehyde and stained with Giemsa solution. Each experiment was done in triplicate and repeated at least three times.
Soft agar colony assays Anchorage-independent growth was tested by suspension of 2610 5 cells in 0.26% agar in normal tissue culture medium in 60 mm plates over a bottom layer of 0.65% agar in medium. The cells were allowed to grow for 14 ± 20 days with refeeding weekly. The live cells in colonies were stained with p-iodotetrazolium violet (Sigma Chemical Corporation., St. Louis, MI, USA) overnight. Experiments were carried out three times in duplicate.
Tumorigenicity assays
Tumorigenicity tests were performed as described earlier (Huang et al., 1994a . Brie¯y, 5610 5 cells in log phase of growth were injected into the subcutaneous shoulder p53 and Egr-1 additively suppress growth I de Belle et al regions of BALB/c nu/nu mice. The mice were inspected for tumor formation twice weekly and sacri®ced when the tumor size was less than 1.5 cm diameter. Tumorigenicity was measured as tumor growth in mg/day and compared for each cell line. The results were statistically analysed by the students unpaired t-test. Dierences between the indicated samples were taken as signi®cantly dierent at P50.05.
UV-C irradiation and apoptosis assays UV irradiation To irradiate cells, the growth medium was removed and cells were irradiated directly in culture dishes using a Stratalinker 2400 (Stratagene, La Jolla, CA, USA), with a metered dose of UV-C radiation. Immediately after irradiation (seconds later), the growth medium was replaced and the cells incubated for the indicated time period.
DNA fragmentation assay Fragmented DNA was assessed following the method described earlier (Frisch and Francis, 1994) .
Flow cytometry For¯ow cytometry, both¯oating and adherent cells were collected by gentle scraping in the growth medium. Cells were washed by gentle resuspension in cold PBS and then ®xed in ice cold methanol. RNA was digested with RNAse A and cellular DNA was stained with propidium iodide followed by analysis using a Becton Dickinson FACSort¯ow cytometer. Cytometer results were analysed using ModFit software.
Caspase activity Caspase-3 activity was assayed using the ApoAlert caspase-3 assay kit according to the manufacturer's instructions (Clontech, Palo Alto, CA, USA).
Analysis of Jun kinase and Erk (MAPK) activities
JNK activity was determined as previously described using a GST fusion protein containing the amino-terminal 79 amino acids of c-Jun. The fusion protein was used for kinase capture and in vitro phosphorylation as described (Hibi et al., 1993) . Erk MAP kinase activity was measured in lysates containing 50 mg protein by incubation with 10 ml of agarose beads conjugated to anti-Erk-1 antibodies (sc-94AC, Santa Cruz Biotechnology, CA, USA). After washing the beads, the complex was incubated with [ 32 P]-g-ATP and a peptide substrate derived from myelin basic protein (MBP). Phosphorylated MBP was detected by SDS ± PAGE followed by autoradiography.
Abbreviations FACS,¯uorescence-activated cell sorting; FAK, focal adhesion kinase; FN, ®bronectin; JNK, jun kinase; PBS, phosphate buered saline; PAI-1, plasminogen activator inhibitor-1; TGFb, transforming growth factor b.
